report of one case of agranulocytosis after clozapine treatment
نویسندگان
چکیده
introduction : clozapine is the first effective antipsychotic drug with the least extra pyramidal side effects and more agranulocytosis than other standard neuroleptics. granolocytopenia or agranulocytosis occurs in 1 to 2 percent of all patients treated with clozapine. agranulocytosis due to clozapine is a fatal disorder that requires immediate clinical intervention. method : this paper reports agranulocytosis after clozapine treatment in a 52 years old women with chronic schizophrenia. conclusion: since agranulocytosis after clozapine treatment is rare and its side effects in psychotic patients are very few, it seems that clozapine with regular blood cell count is an effective drug in the treatment of refractory schizophrenia, patients with tradive dyskinesia and those experiencing severe extra pyramidal side effects.
منابع مشابه
Clozapine-induced agranulocytosis after 11 years of treatment.
http://ajp.psychiatryonline.org 2. Narendran R, Young CM, Valenti AM, Nickolova MK, Pristach CA: Is psychosis exacerbated by modafinil? (letter). Arch Gen Psychiatry 2002; 59:292–293 3. Spensley J, Rockwell DA: Psychosis during methylphenidate abuse. N Engl J Med 1972; 286:880–881 4. Leong GB, Shaner AL, Silva JA: Narcolepsy, paranoid psychosis, and analeptic abuse. Psychiatr J Univ Ott 1989; 1...
متن کاملAgranulocytosis during Clozapine Therapy
Sir, This is in response to the article' Do Indian researchers read Indian research? a reappraisal, four years later', published in April 2000 (No.2, f Vol.42) issue of your journal. The authors of this article have documented their observations on my article 'Transsexualism in Schizophrenia : a case report' (April, 1998, Vol.40, No.2) that I did not refer to their article, 'Behaviour Therapy f...
متن کاملClozapine, agranulocytosis, and benign ethnic neutropenia.
C lozapine is an atypical antipsychotic that is effective in treatment resistant schizophrenia. The National Institute for Health and Clinical Excellence (NICE) guidelines for schizophrenia specify that ‘‘in individuals with evidence of treatment resistant schizophrenia, clozapine should be introduced at the earliest opportunity’’. A severe adverse effect of clozapine that limits its more wides...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
روانپزشکی و روانشناسی بالینی ایرانجلد ۵، شماره ۳، صفحات ۱۸-۲۲
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023